PNU-159682 CAS:202350-68-3, a powerful anthracycline metabolite of Nemorubicin, exhibits exceptional cytotoxicity as a DNA topoisomerase II inhibitor and outperforms Doxorubicin in ADC synthesis, making it an ideal candidate for overcoming drug resistance using EDV-nanocell technology.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
